Company Information

Avalon GloboCare Corp. (NASDAQ: ALBT) is a clinical-stage biotechnology company and laboratory testing provider dedicated to developing and delivering innovative, transformative CellTech (cell-based technologies and therapeutics), precision diagnostics, and clinical laboratory services. Operating through our dual engines, Avalon’s “CellTech + Lab Services” platforms cover the areas of cellular immunotherapy and precision diagnostics. Our laboratory services offer an extensive test menu that will satisfy most clients' testing needs, from general bloodwork to anatomic pathology, urine toxicology, pharmacogenomics (PGx) testing and more; we are a one-stop-shop for most clinical testing. We are also developing next-generation of companion diagnostics related to cell-based therapies to improve rational patient selection and clinical outcome. Overall, we aim to achieve better and safer next-generation cellular immunotherapy.